alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32(b)

              SECTION 1350 Certification (Chief Financial Officer)

In connection with the Quarterly Report of Coastal Financial  Corporation,  Inc.
(the  "Company")  on Form 10-Q for the period  ended June 30, 2005 as filed with
the Securities and Exchange Commission (the "Report"), I Jerry L. Rexroad, Chief
Financial Officer of the Company,  certify,  pursuant to 18 U.S.C.  ss.1350,  as
adopted pursuant to ss.906 of the  Sarbanes-Oxley  Act of 2002, that to the best
of my knowledge:

1.    The Report fully complies with the  requirements of Section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and

2.    The information  contained in the Report fairly presents,  in all material
      respects, the financial condition and results of operations of the Company
      as of and for the period covered by the Report.

This Certification is provided as of August 9, 2005.


                                                  /s/ Jerry L. Rexroad
                                                  ------------------------------
                                                  Jerry L. Rexroad
                                                  Executive Vice President and
                                                  Chief Financial Officer


                                       35
Appeal Dismissed and Memorandum Opinion filed January 10, 2019.

In The 

Fourteenth Court of Appeals 

NO. 14-18-00779-CV

LINDSEY J. LEARD, Appellant 

V.

WELLS FARGO BANK, NA, Appellee 

On Appeal from the 56th District Court 

Galveston County, Texas 

Trial Court Cause No. 18-CV-0397 

M E M O R A N D U M O P I N I O N 

This is an appeal from a final judgment signed August 7, 2018. Appellant’s 

brief was due November 5, 2018. No brief or motion for extension of time to file the 

brief was filed. 

On November 13, 2018, the court ordered appellant to filed a brief by 

December 5, 2018. We cautioned that if appellant failed to comply with our order, 

we would dismiss the appeal for want of prosecution. See Tex. R. App. P. 42.3(b).

No brief or motion for extension of time to file the brief was filed.
Therefore, the appeal is DISMISSED. 

PER CURIAM 

Panel consists of Justices Christopher, Hassan, and Poissant.
Public Hearing on NPRM MDE Rule

May 8, 2012

 Notice of Proposed Rulemaking to establish standards for accessible medical diagnostic 

equipment.

 Comment period closes on June 8, 2012

Hearing Procedures

 Registered speakers may speak for 5 minutes each

 After all registered speakers have presented, there will be an open microphone session 

for others to testify

 Notify staff at the registration desk if you want to testify and have not preregistered

 Please turn off or silence your cell phone

Hearing Procedures

 Transcript will be kept and will be entered into the docket

 Written remarks or PowerPoint shows should be given to the staff at the registration 

desk

 Refrain from reacting publicly to witness presentations or Board member statements
**Exhibit 23.1**

 

 

Consent of IndependentCertified Public AccountantsBoard of DirectorsSherwood Brands, Inc.

 

 

We hereby consent to theincorporation by reference in the Registration Statements on Form S-8(333-56460) and Form S-3 (333-92012) of our reports dated October 10, 2003relating to the consolidated financial statements and schedule of SherwoodBrands, Inc. appearing in the Company’s Annual Report on Form 10-K for the yearended July 31, 2003.

 
| BDO Seidman,  LLP   |
|---------------------|
| Bethesda,  Maryland |
|                |
|                |
| October 28,  2003   |

 

1

----
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Commodity Futures Trading Commission

# Agency Holding the Meeting:

Commodity Futures Trading Commission.

# Time and Date:

1:00 p.m., Monday, October 30, 2000.

# Place:

1155 21st St., NW., Washington, DC, Lobby Level Hearing Room.

# Status:

Open.

# Matters to be Considered:

 

      - Final rules for a regulatory framework for Multilateral Transaction Execution Facilities, Intermediaries and Clearing Organizations.
      - Final rules relating to Intermediaries of Commodity Interest Transactions.
      - Final rules for a New Regulatory Framework for Clearing Organizations.
      - Final rules on the Exemption for Bilateral Transactions.

# Contact Person for More Information: 

Jean A. Webb, 202-418-5100.

Jean A. Webb,

Secretary of the Commission.

[FR Doc. 00-27501  Filed 10-20-00; 5:06 pm]

BILLING CODE 6351-01-M
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

IN THE INTEREST OF A. F. J. and A. K. 

R. CHILDREN,

 

 Appellant. 

§

§

§

§

§

§

§

No. 08-18-00155-CV

Appeal from the

109th District Court

of Andrews County, Texas 

(TC# 20783)

O R D E R

In order to protect the identity of the minor child who is the subject of this appeal, the Court 

has determined on its own motion that it is necessary to identify the children by their initials, A.

F. J. and A. K. R, and the parent by initials as well, in all papers submitted to the Court, including 

letters, motions, and briefs. See Tex.R.App.P. 9..8. The Court will also refer to the children and 

parent by their initials in correspondence, orders, and in its opinion and judgment.

IT IS SO ORDERED this 5

th day of September, 2018.

PER CURIAM

Before McClure, C.J., Rodriguez and Palafox, JJ.
**Exhibit32.2**

 

**Certification********Pursuant to Section 906of the Sarbanes-Oxley Act of 2002****(Subsections (a) and (b) ofSection 1350, Chapter 63 of Title 18, United States Code)**

 

 

Pursuantto Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b)of Section 1350, Chapter 63 of Title 18, United States Code),the undersigned officer of *SOURCECORP*,Incorporated, a Delaware corporation (the “Company”), does hereby certify that:

 

TheQuarterly Report on Form 10-Q/A for the quarter ended March 31, 2004 (the“Form 10-Q/A”) of the Company fully complies with the requirements of Section 13(a)or 15(d) of the Securities Exchange Act of 1934 and information contained inthe Form 10-Q/A fairly presents, in all material respects, the financialcondition and results of operations of the Company.

 

 
| Dated:  March 23, 2005 |    /s/ Barry L. Edwards               |   |
|----------------------------------|------------------------------------------------------|--------|
|                             | Barry L. Edwards                                     |
|                             | Executive Vice President and Chief Financial Officer |

 

 

Theforegoing certification is being furnished solely pursuant to Section 906of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350,Chapter 63 of Title 18, United States Code).

 

----
<TABLE> <S> <C>


<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                             166
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                   209
<PP&E>                                              76
<DEPRECIATION>                                      70
<TOTAL-ASSETS>                                     215
<CURRENT-LIABILITIES>                              124
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                       215
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-BASIC>                                       0.00
<EPS-DILUTED>                                     0.00



</TABLE>
Second Amendment to Amended and Restated 1995 Stock Option Plan



 Exhibit 10.30 
  
 SECOND AMENDMENT 
 TO THE 
 CAREMARK RX, INC. 1995 STOCK OPTION PLAN 
 (FORMERLY THE AMENDED & RESTATED MEDPARTNERS, INC. 
 1995 STOCK OPTION PLAN) 
  
 This Second Amendment to the Caremark Rx, Inc. 1995 Stock Option Plan
(formerly the Amended & Restated Medpartners, Inc. 1995 Stock Option Plan) (the “Plan”) to be effective as of January 12, 2001. 
  
 WITNESSETH: 
  
 WHEREAS, Caremark Rx, Inc. (the “Company”) currently sponsors and maintains the Caremark Rx, Inc. 1995 Stock Option Plan (formerly the
Amended & Restated Medpartners, Inc. 1995 Stock Option Plan) (the “Plan”); and 
  
 WHEREAS, Section 11 of the Plan grants the Compensation Committee of the Board the power at any time to amend the Plan, and the Compensation
Committee now wishes to amend the Plan to modify the vesting provisions for options granted under the Plan on and after January 12, 2001; 
  
 NOW, THEREFORE, the Plan is hereby amended as indicated below: 
  
 1. 
  
 Section 6.4 of the Plan is amended effective as of January 12, 2001, to read as follows: 
  
 6.4 Vesting of Options. Except as set forth by the Committee
in the applicable Option Agreement, Options granted pursuant to the Plan shall vest as follows: 
  
 (a) 34% of the Options shall vest on the Grant Date; 
  
 (b) 33% of the Options granted shall vest on each of the first anniversary and second anniversary of the
Grant Date; provided, however, that for Options granted prior to January 12, 2001, if during 
  
 Second Amendment to the 
 Caremark Rx, Inc. 1995 Stock Option Plan 
 Page 1 







 the first year after the Grant Date, the stock price of the Common Stock closes at or above $12.00 (or
such other price as determined by the Committee and set forth in the applicable Option Agreement) for any twenty (20) out of thirty (30) consecutive trading days, the 33% of the Options due to vest on the first anniversary of the Grant
Date shall vest immediately at the end of such 20th day, and provided, however, that for Options granted prior to January 12, 2001, if during the second year after the Grant Date, the stock price of the Common Stock closes at or above $18.00
(or such other price as determined by the Committee and set forth in the applicable Option Agreement) for any twenty (20) out of thirty (30) consecutive trading days, the 33% of the Options due to vest on the second anniversary of the
Grant Date shall vest immediately at the end of such 20th day. 
  
 2. 
  
 The name of the Plan is changed effective as of
January 12, 2001 from the Amended & Restated Medpartners, Inc. 1995 Stock Option Plan to the Caremark Rx, Inc. 1995 Stock Option Plan. All references in any Company documents to the Amended & Restated Medpartners, Inc. 1995
Stock Option Plan shall, after January 12, 2001, be a reference to the Caremark Rx, Inc. 1995 Stock Option Plan. 
  
 3. 
  
 All other provisions of the Plan not inconsistent herewith are hereby confirmed and ratified. 
  
 Approved by the Board of Directors 
 by resolutions on January 12, 2001. 
  
 Second Amendment to the 
 Caremark Rx, Inc. 1995
Stock Option Plan 
 Page 2
Exhibit 32

CERTIFICATION PURSUANT TO 18. U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

The undersigned executive officers of BCSB Bankcorp, Inc. (the Company) hereby certify that this Annual Report on Form 10-K for the year ended September 30, 2007 (the Report) fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period
covered by the Report.



By:

/s/ Joseph J. BouffardName:

Joseph J. BouffardTitle:

President and Chief Executive OfficerBy:

/s/ Anthony R. ColeName:

Anthony R. ColeTitle:

Executive Vice President and Chief Financial Officer


Date: December 28, 2007
EXHIBIT 23.2
 
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
 
        We consent to the incorporation by reference in the Registration
Statement (Form S-8 No. 333-66139) pertaining to the 1995 Stock Option
Plan, the 1997 Equity Incentive Plan, the 1998 Non-Employee Directors'
Stock Option Plan, the 1998 Employee Stock Purchase Plan and Non-Plan
Option Grants of Terayon Communication Systems, Inc. of our report dated
January 15, 1999, with respect to the consolidated financial statements
of Terayon Communication Systems, Inc. included in the Annual Report
(Form 10-K) for the year ended December 31, 1998.
 
        Our audits also included the financial statement schedule of Terayon
Communication Systems, Inc. listed in Item 14(c).  The schedule is the
responsibility of the Company's management.  Our responsibility is to
express an opinion based on our audits. In our opinion, the financial
statement schedule referred to above, when considered in relation to the
basic financial statements taken as a whole, presents fairly in all
material respects the information set forth therein.
 
                                          /s/ Ernst & Young LLP
 
 
San Jose, California
March 23, 1999
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIAID.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Allergy and Infectious Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                        Board of Scientific Counselors, NIAID.                    

*Date:*                        December 11-13, 2000.                    

*Time:*                        December 11, 2000, 8 am to adjournment on December 13.                    

*Agenda:*                        To review and evaluate personal qualifications and performance, and competence of individual investigators.                    

*Place:*                        National Institutes of Health, Building 4, Conference Room 433, 10 Center Drive, Bethesda, MD 20892.                    

*Contact Person:*                         Thomas J. Kindt, PhD, Director, Division of Intramural Research, National Inst. of Allergy & Infectious Diseases, Building 10, Room 4A31, Bethesda, MD 20892, 301 496-3006, tk9c@nih.gov.                    

                        (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology,                               ( print page 64977)                            and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)                    

Dated: October 18, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-27883  Filed 10-30-00; 8:45 am]

BILLING CODE 4140-01-M
Exhibit
32.2









CERTIFICATION
PURSUANT TO SECTION 1350 OF CHAPTER 63


OF TITLE
18 OF THE UNITED STATES CODE








I, Rhowena Blank, the Vice President,
Accounting Officer and principal financial officer of Man Investments (USA)
Corp., the general partner of Man-AHL Diversified I L.P. (the “Partnership”),
certify that (i) the Annual Report of the Partnership on Form 10-K for the
period ending December 31, 2008 fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information
contained in such Report fairly presents, in all material respects, the
financial condition and results of operations of the Partnership.








Date: March 31,2009








/s/ Rhowena
      BlankRhowena
      BlankVice
      President, Accounting Officer
Testimony of Walter Tsou, MD, MPH, Philadelphia Physicians for Social Responsibility on Carbon Pollution from Existing Power Plants

July 29, 2014

To the Members of the EPA Panel:

My name is Dr. Walter Tsou. I chair the board of Philadelphia Physicians for Social Responsibility and have served in the past as Health Commissioner of Philadelphia. I applaud the EPA for forwarding your Clean Power Plan that sets achievable goals for states in order to reduce carbon pollution nationwide. We are also likely to have additional benefits of reducing S02, mercury, PM 2.5, ground level ozone and nitrogen oxide.

T he National Climate Assessment leaves no doubt that the burning of fossil fuels has produced carbon pollution that has made climate change and global warming a public health threat of epic proportions. As a public health physician, I have witnessed permanent environmental destruction from fracking, extreme weather changes forcing serious displacement of people and property across the world, island countries at risk of being submerged as sea levels rise, asthma as the leading medical reason for school truancy, heat reiated deaths after prolonged heat waves, fish contaminated by mercury, and tropical diseases previously unseen in temperate climates. These are only within my personal limited lifespan which is a mere speck of Earth's lifespan. In short, we are seeing seismic changes unraveling before our very eyes.

As stewards of our planet and as responsible parents to our children, we cannot sit on our hands while we know that we are facing a global crisis of immense proportions.

These proposed regulations are important, but the bare minimal steps that need to be taken. Indeed, I would argue that these measures do not go far enough. In crafting these regulations, we recognize that how states achieve these goals will vary, but we also know that these restrictions will force renewed attention to renewable energy sources. It is the latter goal of moving us toward renewable sources that could transform how we prepare America for our energy needs for future generations. Electric cars will transform how we consume fossil fuels. Future homes will have geothermal wells, energy efficient windows and appliances, and solar panel roof shingles. More of us will be vegetarians.

Opponents to these regulations will argue that the cost of energy will go up and that we are decades away from the utopian dream of renewable energy. In terms of costs, consider the economic cost of the drought in California, the rebuilding of New Orleans, New York and New Jersey after their hurricanes, the bleak future for our children on a planet that is two degrees warmer. And in terms of the "pie in the sky", renewable energy? Well I think we are up to the challenge. America does best when we have our eyes on a goal and we use our creativity to achieve it. The technology exists today. These rules will start moving us in the right direction.
**Exhibit 10.4****ASSIGNMENT OF TRADEMARK REGISTRATIONS**ASSIGNMENT OF TRADEMARK REGISTRATIONS     WHEREAS, GETTY OIL COMPANY, a Delaware corporationlocated and doing business at 3810 Wilshire Boulevard, LosAngeles, California 90054 is the owner of the trademarkregistrations set forth in the annexed Schedule A; and     WHEREAS, POWER TEST CORP., a Delaware corporationlocated and doing business at 175 Sunnyside Boulevard,Plainview, New York 11803 is desirous of acquiring saidtrademark registrations and the goodwill of the businesssymbolized by the trademarks covered by said registrations;     NOW, THEREFORE, for good and valuable consideration,receipt of which is hereby acknowledged, said GETTY OILCompany, does herby assign unto said POWER TEST CORP. allright, title and interest in and to the trademark registrationsidentified in the annexed Schedule A together withthe goodwill of the business symbolized by the trademarkscovered by said registrations.     This Agreement is executed at White Plains, NewYork, this 11th day of July, 1985.      GETTY OIL COMPANY